Divya B. Reddy

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/f08dec40-c946-11ed-8462-993dfb204153.jpg

First Name

Divya

Last Name

Reddy

NPI

1588828370

Faculty ID

14312

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><strong><span style="font-size: 12pt; font-family: Calibri;">Education:</span></strong></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><span style="font-size: 12pt; font-family: Calibri;">Dr. Reddy earned her medical degree from Padmashree Dr. D. Y. Patil Medical College, India. She completed a master's degree in clinical epidemiology from Boston University School of Public Health prior to starting her Internal Medicine Residency training at Boston University Medical Center. Her post-graduate training also included a Fellowship in Pulmonary and Critical Care Medicine from Boston University Medical Center with a particular focus on pulmonary infections and associated lung destruction.&nbsp;&nbsp;</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><strong><span style="font-size: 12pt; font-family: Calibri;">Research Interests:</span></strong></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><span style="font-size: 12pt; font-family: Calibri;">Dr. Reddy has been involved in several patient-oriented research projects in pulmonary infections. As an investigator in the Regional Prospective&nbsp;Observational Research in Tuberculosis (RePORT) cohort in Puducherry and Tamil Nadu, India&nbsp;her work focused on the impact of smoking and biomass fuel use on TB Disease and its treatment outcomes.&nbsp;She is&nbsp;currently developing a database of patients with non-tuberculous mycobacterial infections seen at Montefiore Medical Center in collaboration with the Division of Infectious Diseases. The goal of this project is to better characterize the natural history&nbsp;and clinical outcomes of these infections.&nbsp;&nbsp;She is also involved in the&nbsp;Women&rsquo;s Interagency HIV Study (WIHS) as the Bronx site pulmonologist and co-investigator to assess the impact of HIV on the development of chronic lung diseases.</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><span style="font-size: 12pt; font-family: Calibri;"><strong>Clinical Interests:</strong></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">1. Bronchiectasis &nbsp; &nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">2. Tuberculosis</span></p>
<p class="MsoNormal" style="margin: 0in -67.5pt 0.0001pt 0in; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">3. Nontuberculous Mycobacterial (NTM) Infections &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">4. Obstructive lung diseases &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">5. COVID-19</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">&nbsp;</p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><strong><span style="font-size: 12pt; font-family: Calibri;">Board Certification:</span></strong></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><span style="font-size: 12pt; font-family: Calibri;">Dr. Reddy is board-certified in Internal Medicine, Pulmonary and Critical Care Medicine and is a<span class="apple-converted-space">&nbsp;</span><span style="border: 1pt none windowtext; padding: 0in;">member of numerous professional societies, including the American Thoracic Society and the Society of Critical Care Medicine.</span></span></p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Bronchiectasis, Nontuberculous Mycobacterial infections, COPD, Asthma, Interstitial Lung Disease<quillbot-extension-portal></quillbot-extension-portal><quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Bronchiectasis, Nontuberculous mycobacterial infections.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

Selected Publications

<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; text-align: justify; text-indent: 4.5pt;"><strong><span style="font-family: Calibri;">Original Publications:</span></strong></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; text-align: justify; text-indent: 4.5pt;"><span style="font-family: Calibri;">&nbsp;</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">1.&nbsp;&nbsp;&nbsp;&nbsp;<strong>Reddy D</strong>, Little F; Glucocorticoid-Resistant Asthma: More than meets the eye;&nbsp;<em>J Asthma</em>&nbsp;December 2013, Vol. 50, No. 10, Pages 1036-1044, PMID 23923995</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">2.&nbsp;&nbsp;&nbsp;&nbsp;<strong>Reddy D</strong>, O&rsquo;Donnell MR, Welter-Frost AM, Coe A, Horsburgh CR. Discordance between Tuberculin Skin Test and Interferon Gamma Release Assay is Associated with Previous Latent Tuberculosis Infection Treatment.&nbsp;<em>Mycobact Dis</em>&nbsp;2016, 6:227. doi: 10.4172/2161-1068.1000227.</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Divya Reddy</strong>, Jacob Walker, Gary Brandeis MD, Matt Russell MD, C Robert Horsburgh Jr, Natasha Hochberg;&nbsp;Latent Tuberculosis Infection Screening Practices in Long-Term Care Facilities<em>;&nbsp;J Am Geriatr Soc</em>, 2017, 65: 1145&ndash;1151. doi:10.1111/jgs.14696, PMID 28467605</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">4.&nbsp; &nbsp; &nbsp;</span><strong style="font-family: Cambria; font-size: 12pt;"><span style="font-family: Calibri;">Divya Reddy</span></strong><span style="font-size: 12pt; font-family: Calibri;">, Yicheng Ma, Subitha Lakshminarayanan, Swaroop Sahu, Laura F. White, Ayiraveetil Reshma, Gautam Roy, Padmini Salgame, Selby Knudsen, Jerrold J. Ellner, C. Robert Horsburgh, Jr., Sonali Sarkar, Natasha S. Hochberg, Severe Undernutrition in Children Affects Tuberculin Skin Test Performance in Southern India. <em>PLoS ONE 16(7): e0250304. https://doi.org/10.1371/journal. pone.0250304, </em></span><span style="font-size: 12pt; font-family: Calibri;">PMID 34270546</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Cambria;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Cambria;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in -0.25in 0.0001pt 40.5pt; font-size: medium; font-family: Cambria; text-indent: 4.5pt;"><span style="font-family: Calibri;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in -0.25in 0.0001pt 40.5pt; font-size: medium; font-family: Cambria; text-indent: -0.5in;"><strong><span style="font-family: Calibri;">Book Chapters:</span></strong></p>
<p class="MsoNormal" style="margin: 0in -0.25in 0.0001pt 40.5pt; font-size: medium; font-family: Cambria; text-indent: 4.5pt;"><span style="font-family: Calibri;">&nbsp;</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;O&rsquo;Donnell M,&nbsp;<strong>Reddy D</strong>, Saukkonen J; Antimycobacterial agents; 19^th&nbsp;Edition of&nbsp;<em>Harrison&rsquo;s Principles of Internal Medicine</em>, McGraw-Hill Professional, 2015. Volume 2. Chapter 205e, p. 1132-41</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Reddy D</strong>, O&rsquo;Donnell M; Antimycobacterial agents; 20^th&nbsp;Edition of&nbsp;<em>Harrison&rsquo;s Principles of Internal Medicine,&nbsp;</em>McGraw-Hill Professional, 2018. Volume 1. Chapter 176, p. 1270-79</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Reddy D</strong>, Saukkonen J; Hepatoxicity associated with anti-tuberculosis treatment;<strong>&nbsp;</strong>3^rd&nbsp;Edition of&nbsp;<em>Textbook of</em>&nbsp;<em>Tuberculosis and Nontuberculous Mycobacterial Diseases,</em>&nbsp;Jaypee Brothers Medical Publishers, 2019. Chapter 45, p. 637-643</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Divya Reddy</strong>, Jerrold Ellner; Pathogenesis of Tuberculosis; 6^th&nbsp;Edition of&nbsp;<em>Clinical Tuberculosis</em>, CRC Press, 2020. Chapter 4, p. 51-76</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri;">&nbsp;</span></p>

EMR ID

73329

Biography

<p>Divya Reddy, MD, MPH, is Program Director, Pulmonary and Critical Care Fellowship and Associate Professor, Medicine at Montefiore Einstein. Her clinical focus centers on bronchiectasis, nontuberculous mycobacterial infections, chronic obstructive pulmonary disease (COPD), asthma and interstitial lung disease.</p><p>After earning her Bachelor of Medicine, Bachelor of Surgery at Dr. D.Y. Patil Medical College in Mumbai, India in 2006, Dr. Reddy moved to the United States to continue her medical training, earning her Master of Public Health at Boston University in 2008. She remained there to complete her internal medicine internship in 2009, followed by her internal medicine residency in 2011. Dr. Reddy then completed a pulmonary and critical care fellowship at Boston University in 2014.</p><p>Building on her clinical experience, Dr. Reddy&rsquo;s research is focused on bronchiectasis and nontuberculous mycobacterial infections. She has been principal investigator and co-investigator on several funded research projects, and her work has been published in numerous peer-reviewed journals, book chapters, review articles and abstracts. She has also given national and international invited presentations, and is a reviewer for scientific journals including the <em>Journal of American Geriatric Society</em>, <em>Annals of American Thoracic Society</em> and the <em>Journal of Infectious &amp; Non-Infectious Diseases</em>, among others.</p><p>Dr. Reddy is board certified in Pulmonary Medicine and Critical Care Medicine by the American Board of Internal Medicine. She is a member of the American Thoracic Society, the American College of Chest Physicians and the Association of Pulmonary and Critical Care Medicine Program Directors. In 2014 and 2015, Dr. Reddy received the Potts Memorial Foundation Grant award.</p>

Visit Type ID

2542

Is Open Scheduling

On

Manish Ramesh

https://assets.montefioreeinstein.org/profiles/images/physphoto/Ramesh_Manish_MD_420x504-2.jpg

First Name

Manish

Last Name

Ramesh

NPI

1639479736

Faculty ID

14132

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Manish Ramesh was appointed assistant professor in the Einstein/Montefiore Division of Allergy and Immunology in July 2014. He is director of the Montefiore Medical Center Food Allergy Centers in Scarsdale and the Bronx.</p>
<p>Dr. Ramesh completed fellowship training in Allergy and Immunology at the Icahn School of Medicine at Mount Sinai and residency training in internal medicine at Jacobi Medical Center, where he was best overall resident (PGY3) in 2011. He attended medical school in India at S.C.B. Medical College and subsequently obtained his Ph.D. in immunology from University of Connecticut Health Center.</p>
<p>Dr. Ramesh is board certified in Allergy and Immunology and Internal Medicine.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5091

Visit Type ID

2498

Is Open Scheduling

On

Zocdoc Link

David J. Prezant

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/4db93d60-5bd2-11ef-9c26-99fb988c3389.jpg

First Name

David

Last Name

Prezant

NPI

1184713489

Faculty ID

2422

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. David Prezant is the Chief Medical Officer at the Office of Medical Affairs for the Fire Department of the City of New York (FDNY). Dr. Prezant directs all medical protocol development for both day-to-day operations and homeland security issues. He is also Co-Director of the FDNY World Trade Center Medical Monitoring Program and the Senior Pulmonary Consultant for FDNY.</p>

<p>Dr. Prezant is a member of the Institute of Medicine's Committee on Personal Protective Equipment in the Workplace, the National Fire Protection Association's Health and Safety Committee, and the International Association of Firefighters Redmond Medical Advisory Board. He is a Professor of Medicine at the Albert Einstein College of Medicine; Director of Albert Einstein Medical School's Pulmonary Course for medical students and the Research Director for their Unified Pulmonary Division.</p>

<p>Dr. Prezant responded on 9/11/01 to the World Trade Center and was present during the collapse and its aftermath. Since that day, he and Dr. Kelly (FDNY's Chief Medical Officer at the Bureau of Health Services) have initiated a multi-million dollar medical monitoring and treatment program for FDNY firefighters funded by FDNY, the Centers for Disease Control and Prevention (CDC) and the National Institute for Occupational Safety and Health (NIOSH).</p>

<p>Dr. Prezant is the Principal Investigator for the FDNY Data Coordinating Center for the WTC Medical Monitoring Program and is on the Steering Committee for the WTC Medical Monitoring Program. He served as a member of the EPA WTC Technical Advisory Committee, the NYC Dept of Health WTC Registry Scientific Advisory Board, the NYS Governor's WTC panel and the NYC Mayor's medical advisory board.</p>

<p>Dr. Prezant has written extensively on pulmonary physiology, firefighter health and safety and since 9/11 on the health impact of World Trade Center Collapse on NYC Firefighters and EMS rescue workers. His group was the first to describe WTC Cough Syndrome (New England Journal of Medicine 2002) and has published extensively on this subject in the CDC MMWR, American Journal of Respiratory and Critical Care Medicine, Chest and Environmental Health Perspectives.</p>

<p>His major research interest is in determining the mechanisms responsible for accelerated decline in longitudinal pulmonary function and/or airway hyperreactivity in firefighters after WTC exposure. Other interests are in determining the mechanisms responsible for the increased incidence of sarcoidosis in firefighters after WTC exposure.</p>

<p><strong>Clinical Specialty Areas</strong></p>

<ul>
<li>environmental and occupational lung disease</li>

<li>firefighters respiratory disease</li>

<li>disaster medicine</li>

<li>pulmonary embolism</li>

<li>general pulmonary medicine</li>
</ul>

<p><strong>More</strong></p>

<p><a href="/medicine/pulmonarymedicine/pulmonary_about.aspx?id=14538">Seven Years Later, a Cough and a Covenant</a> (September 10, 2008)</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<ol>
<li>World Trade Center site. N Eng J Med 2002;347:806-15.</li>

<li>Banauch GI, McLaughlin M, Hirschhorn R, Corrigan M, Kelly KJ, Prezant DJ. Injuries and Illnesses among New York City Fire Department rescue workers after responding to the World Trade Center Attacks. MMWR 2002;51:1-5.</li>

<li>Prezant DJ, Kelly KJ, Jackson B, Peterson D, Feldman D, Baron S, Mueller CA, Bernard B, Lushniak B, Smith L, BerryAnn R, Hoffman B. Use of respiratory protection among responders at the World Trade Center Site, New York City, September 2001. MMWR 2002;51:6-8.</li>

<li>Rom WN, Weiden M, Garcia R, Ting AY, Vathesatogkit P, Tse DB, McGuinness G, Roggli V, Prezant DJ. Acute eosinophilic pneumonia in a New York City firefighter exposed to world trade center dust. Am. J. Resp. Crit. Care Med. 2002;166:797-800.</li>

<li>Banauch GI, Alleyne D, Sanchez R, Olender K, Weiden M, Kelly KJ, and PREZANT DJ. Persistent bronchial hyperreactivity in New York City firefighters and rescue workers following collapse of World Trade Center. Am. J. Resp. Crit. Care Med. 2003; 168:54-62.</li>

<li>Edelman P, Osterloh J, Pirkle J, Grainger J, Jones R, Blount B, Calafat A, Turner W, Caudill S, Feldman DM, Baron S, Bernard BP, Lushniak BD, Kelly KJ, PREZANT DJ. Biomonitoring of chemical exposure among New York City firefighters responding to the World Trade Center fire and collapse. Environ Health Perspect, 2003; 111:1906-1911.</li>

<li>Feldman DM, Baron S, Mueller CA, Bernard BP, Lushniak BD, Kelly KJ, PREZANT DJ. Initial symptoms, respiratory function and respirator use in New York City firefighters responding to the World Trade Center (WTC) disaster. Chest 2004;125:1256-64.</li>

<li>World Trade Center dust. Environ Health Perspect, 2004; 112:1564-1569.</li>

<li>Banauch GI, Dhala A, Alleyne D, Alva R, Santhyadka G, Krasko A, Weiden M, Kelly KJ, Prezant DJ. Bronchial hyperreactivity and other inhalation lung injuries in rescue/recovery workers after the World Trade Center collapse. Crit Care Med. 2005;33:S102-S106.</li>

<li>World Trade Center site. Curr Opin Pulm Med 2005; 11:160-8.</li>

<li>Paul Greene, Dianne Kane, Grace Christ, Sallie Lynch and Malachy Corrigan. FDNY crisis counseling: innovative responses to 9/11 firefighters, families, and communities. Published 2005.A textbook in counseling at FDNY after WTC.</li>

<li>Bars MP, Banauch GI, Appel DW, Andreaci M, Mouren P, Kelly KJ, Prezant DJ. Tobacco Free with FDNY: The New York City Fire Department World Trade Center Tobacco Cessation Study. Chest 2006; 129:979-987.</li>

<li>World Trade Center exposure in the New York City Fire Department. Am. J. Respir. Crit. Care Med. 2006; 174:312-319.</li>

<li>Friedman S, Cone J, Eros-Sarnyai M, Prezant D,m Szeinuk J, Clark N, Milek D, Levin S, Gillio R. Clinical guidelines for adults exposed to World Trade Center Disaster (Respiratory and Mental Health). City Health Info (CHI), NYC Department of Health and Mental Hygiene. September 2006</li>

<li>Lioy PJ, Pellizzari E, and Prezant DJ. Understanding and learning from the WTC Aftermath and its affect on health through Human Exposure Science. Environ. Science Technology. November 15, 2006 ; 6876-6885.</li>

<li>Izbicki G, Chavko R, Banauch GI, Weiden M, Berger K, Kelly KJ, Aldrich TK and Prezant DJ. World Trade Center Sarcoid-like Granulomatous Pulmonary Disease in New York City Fire Department Rescue Workers. CHEST (In press)</li>

<li>Izbicki G, Chavko R, Banauch GI, Weiden M, Berger K, Kelly KJ, Hall C, Aldrich TK and Prezant DJ.&#160; World Trade Center Sarcoid-like Granulomatous Pulmonary Disease in New York City Fire Department Rescue Workers.&#160; Chest, 2007;131:1414-1423</li>

<li>Weiden M, Banauch G, Kelly KJ, and Prezant DJ. Environmental and Occupational Medicine. Firefighters Health and Health Effects of the World Trade Center Collapse. Pgs 477-490. 4th Edition, Edited by Rom WN and Markowitz S. Lippincott-Raven Inc. Philadelphia, 2007.</li>

<li>Alvarez J, Rosen C, Davis K, Smith G, Corrigan M. Stay Connected : psychological services for retired firefighters after 11 September 2001.&#160; PreHospital Disaster Med. 2007 ;22 :49-54.</li>

<li>Menendez AM, Molloy J., Magaldi MC. Health responses of New York City firefighter spouses and their families post-September 11, 2001 terrorist attacks.&#160; Issues Ment Health Nurs. 2006; 27:905-17.</li>

<li>Kelly KJ, Niles J, McLaughlin MT, Carrol S, Corrigan M, Al-Othman F, and Prezant DJ.&#160; World Trade Center health Impacts on FDNY Rescue Workers - a six year assessment, September 2001 to 2007.&#160; Fire Department of the City of New York, October 2007. Available on-line at: <a href="http://www.nyc.gov/html/om/pdf/2007/wtc_health_impacts_on_fdny_rescue_w…; target="_blank">http://www.nyc.gov/html/om/pdf/2007/wtc_health_impacts_on_fdny_rescue_w…;

<li>Prezant DJ. WTC Cough Syndrome and its Treatment. Lung. 2008 ; 186 :94S-102S.</li>

<li>Banauch GI, Izbicki G, Chavko R, Christodoulou V, Weiden MD, Webber MP, Cohen HW, Gustave J, Aldrich TK, Kelly KJ, and Prezant DJ. Trial of Prophylactic Inhaled Steroids to Prevent or Reduce Pulmonary Function Decline, Pulmonary Symptoms and Airway Hyperreactivity in Firefighters at the World Trade Center Site. Disaster Medicine and Public Health Preparedness 2008; 2:33-39.</li>

<li>Prezant DJ, Levin S, Kelly KJ, Aldrich TK.&#160; Upper and Lower Respiratory Diseases after Occupational and Environmental Disasters.&#160; Mt. Sinai Medical Journal (In Press).&#160;&#160;&#160;&#160;&#160;</li>
</ol>

<p>&#160;</p>

EMR ID

3430

Is Open Scheduling

Off

Kenneth L. Pinsker

https://assets.montefioreeinstein.org/profiles/images/physphoto/Pinsker_Kenneth_MD_420x504.jpg

First Name

Kenneth

Last Name

Pinsker

NPI

1306936273

Faculty ID

3368

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Languages

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Kenneth Pinsker is Professor Emeritus of Medicine at Einstein and an attending physician at Montefiore. He is the former Chief of the Pulmonary Service at the Moses Division and the former Director of the Pulmonary Intensive Care Unit. He is currently a preceptor in the Pulmonary Clinic and makes teaching rounds on the consultation service.</p>
<p><strong>Clinical Specialty Areas</strong></p>
<ul>
<li>pulmonary function</li>
<li>bronchoscopy</li>
<li>pleural disease</li>
<li>general pulmonary medicine</li>
</ul>
<p><strong>Academic and Research Interests </strong></p>
<ul>
<li>lung transplantation</li>
<li>tuberculosis</li>
<li>respiratory failure</li>
<li>World-Trade-Center-related pulmonary disease</li>
<li>history of pulmonary medicine</li>
</ul>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

3427

Is Open Scheduling

Off

Sami A. Nachman

https://assets.montefioreeinstein.org/profiles/images/physphoto/Nachman_Sami_MD_420x504.jpg

First Name

Sami

Last Name

Nachman

NPI

1255491932

Faculty ID

13896

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5711

Visit Type ID

2542

Is Open Scheduling

On

Zocdoc Link

Ali Y. Mansour

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/707c8b40-470d-11ec-9350-298b34a4a389.jpg

First Name

Ali

Last Name

Mansour

NPI

1427279017

Faculty ID

17102

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

C<span style="color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">linical focus includes interventional pulmonary medicine, interstitial lung disease, lung transplantation, vascular medicine and sleep medicine.</span><quillbot-extension-portal></quillbot-extension-portal>

Research Focus

<span style="color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Mansour&rsquo;s research focuses on lung transplant and extracorporeal membrane oxygenation (ECMO) support during critical illnesses from severe lung disease.</span><quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

124228

Biography

<p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Ali Mansour, MD, is Medical Director, Advanced Pulmonary Failure and Lung Transplantation and Assistant Professor at Montefiore Einstein. His clinical focus includes interventional pulmonary medicine, interstitial lung disease, lung transplantation, vascular medicine and sleep medicine.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">In 2000, Dr. Mansour received his Bachelor of Chemistry at the American University of Beirut. He continued his studies at this institution and received his Doctor of Medicine in 2004. Dr. Mansour began his postgraduate training in 2004 with a yearlong internship at the American University of Beirut Medical College. His training then took him to Kansas, where he completed an internship and residency in internal medicine in 2008 at the Kansas University Medical School. Following this, Dr. Mansour completed a fellowship in pulmonary and critical care that included advanced fellowship training in pulmonary transplantation at Baylor College of Medicine in 2011. In 2012, he completed a sleep fellowship at the University Hospital Case Western Medical Center. Dr. Mansour is board certified in echocardiography and vascular medicine and is accredited as an interventional pulmonologist.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Mansour&rsquo;s research focuses on lung transplant and extracorporeal membrane oxygenation (ECMO) support during critical illnesses from severe lung disease. He is also interested in lung cancer staging and advanced airway procedure to improve and prolong survival. More recently, he supervises numerous clinical studies and trials including novel therapies for SARS-CoV-2. His work has been published in a number of peer-reviewed publications, and he has been an invited speaker to numerous national oral presentations.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Mansour is a member of numerous professional societies, including the American Thoracic Society, the American Academy of Sleep Medicine and the American Association for Bronchology and Interventional Pulmonology. He is a fellow of the American College of Chest Physicians.</p>

Is Open Scheduling

Off

Sunit P. Jariwala

https://assets.montefioreeinstein.org/profiles/images/Jariwala_Sunit_MD_2x.jpg

First Name

Sunit

Last Name

Jariwala

NPI

1447411814

Faculty ID

12680

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Sunit P. Jariwala is the Medical Director of Digital Transformation of the Faculty Practice Group and the Director of Clinical &amp; Research Innovation of the Department of Medicine at the Albert Einstein College of Medicine and Montefiore Medical Center. He also serves as the Director of Allergy/Immunology Research for the Division of Allergy/Immunology and Co-Director of the Montefiore Asthma Center. Dr. Jariwala's clinical practice covers all aspects of allergy, asthma, and immunologic diseases in children and adults. Dr. Jariwala serves on the Editorial Board of the <em>Journal of Allergy and Asthma</em>. To date, Dr. Jariwala has published over 75 peer-reviewed articles in top-tier journals such as the <em>New England Journal of Medicine, Lancet Respiratory Medicine, Allergy, Journal of Allergy and Clinical Immunology,&nbsp;</em>and&nbsp;<em>Applied Clinical Informatics.&nbsp;</em>He has&nbsp;received 22 clinical research grants (PI on 14 grants) for his work regarding novel information technology-based asthma education interventions for patients. Grant funding sources have included the NIH/NHLBI, Agency for Healthcare Research and Quality, Price Family Foundation, New York Regional Center for Diabetes Translation Research, and the Einstein Global Health Center. He recently served as the Chair of the American Academy of Allergy, Asthma &amp; Immunology's Health Informatics, Technology and Education (HITE) Committee. He has also served as an NIH Study Section member for the Biomedical Computing and Health Informatics Study Section.&nbsp;</p>
<p>Dr. Jariwala has a long-standing interest in quality improvement and medical informatics, especially regarding asthma care delivery. He developed and pilot tested an adult version of the ASTHMAXcel mobile intervention for severe asthma patients. The ASTHMAXcel tool is available for smartphones and tablets, and provides guideline-based asthma education in the ambulatory and emergency department settings. This platform has been extended to other chronic conditions such as type 2 diabetes and was also extended to the emergency department setting. ASTHMAXcel website - www.asthmaxcel.net</p&gt;
<p>Dr. Jariwala is board certified in Allergy/Immunology and Clinical Informatics, and has been recognized with the Physician&rsquo;s Recognition Award with Commendation in Continuing Medical Education by the American Medical Association. He graduated Magna Cum Laude from the Rutgers College General Honors Program and UMDNJ-Robert Wood Johnson Medical School. Dr. Jariwala completed his residency in Internal Medicine and fellowship in Allergy/Immunology at Montefiore Medical Center. Upon the completion of his training, he received the Leo Davidoff Award for outstanding achievement in the teaching of medical students. Dr. Jariwala is a Fellow of the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<p><strong>A. Original Communications in Reviewed Journals:</strong></p>
<p>1. <strong>Jariwala SP</strong>, Crowley JG, Roychowdhury S. Trauma-induced extracranial carotid artery dissection leading to multiple infarcts in a young female. Pediatric Emergency Care. 2006 Oct; 22(10):737-742.</p>
<p>2. Khan AM, <strong>Jariwala SP</strong>, Klapper P. Acute eosinophilic pneumonia with intramuscular progesterone (in oil) following in vitro fertilization. Fertility and Sterility. 2008 Oct; 90(4): 1200.e3-6.</p>
<p>3. <strong>Jariwala SP</strong>, Fodeman J, Rosenstreich D, Hudes G, Ahuja K. Functional antibody deficiency in a patient with type 1 Gaucher disease. Journal of Inherited Metabolic Disease.&nbsp;2008 Dec;31 Suppl 2:S267-70.&nbsp;</p>
<p>4. <strong>Jariwala SP</strong>, Moday H, de Asis ML, Fodeman J, Hudes G, de Vos G, Rosenstreich D. The Urticaria Severity Score (USS), A Sensitive Questionnaire/Index for Monitoring Response to Therapy in Chronic Urticaria. Annals of Allergy, Asthma &amp; Immunology. 2009 Jun; 102: 475-482.</p>
<p>5. Fodeman J, <strong>Jariwala SP</strong>, Hudes G, Wittner M, Klapper P, Rosenstreich D. Scratching the Surface. American Journal of Medicine. 2010 Jan; 123(1): 22-26.</p>
<p>6. Fodeman J, <strong>Jariwala SP</strong>, Hudes G, Jerschow E, Rosenstreich D. Subcutaneous Allergen Immunotherapy in Three Patients with Human Immunodeficiency Virus. Annals of Allergy, Asthma &amp; Immunology. 2010 Oct; 105(4): 320-1.</p>
<p>7. Sharief S, <strong>Jariwala SP</strong>, Kumar J, Muntner P, Melamed M. Vitamin D and food and environmental allergy in the United States: Results from NHANES 2005-2006. J Allergy Clin Immunol. 2011 May; 127(5): 1195-202.</p>
<p>8. <strong>Jariwala SP</strong>, Kurada V, Moday H, Thanjan A, Bastone L, Khananashvili M, Fodeman J, Hudes G, Rosenstreich D. Association between Tree Pollen Counts and Asthma ED Visits in a High-Density Urban Center. Journal of Asthma. 2011 Jun; 48(5): 442-8.</p>
<p>9. <strong>Jariwala SP</strong>, Vernon N, de Vos G. A novel method of desensitization for fluconazole hypersensitivity in a patient with AIDS. Annals of Allergy, Asthma &amp; Immunology. 2011 Jun; 106(6): 542-3.</p>
<p>10. <strong>Jariwala S</strong>, Vernon N, Shliozberg J. Henoch-Schonlein purpura after Hepatitis A vaccination. Annals of Allergy, Asthma &amp; Immunology. 2011 Aug; 107(2): 180-1.</p>
<p>11. <strong>Jariwala S</strong>, Langman Y, Benson A, Wolf E, Moss J, Zhu C, Brandt L. Strongyloidiasis presenting as eosinophilic ascites. Annals of Tropical Medicine &amp; Parasitology. 2011 Jun; 105(4): 335-8.</p>
<p>12. Weiss K,<strong> Jariwala S</strong>, Wachs J, Jerschow E. Fixed drug eruption caused by mesna. Annals of Allergy, Asthma &amp; Immunology. 2011 Oct; 107(4): 377-8.</p>
<p>13. Shum M, <strong>Jariwala SP</strong>, Rosenstreich D. Successful C1 inhibitor prophylaxis during Zenker's diverticulum repair in a patient with hereditary angioedema. Annals of Allergy, Asthma &amp; Immunology. 2012 Feb; 108(2): 126-8.</p>
<p>14. Ferastraoaru DE, Jariwala NN, <strong>Jariwala SP</strong>. Strongyloides stercoralis infection in a patient with sickle cell disease. Annals of Tropical Medicine &amp; Parasitology. 2011; 105(8): 647-50.</p>
<p>15. Rankin BT, <strong>Jariwala SP</strong>. Graded challenge protocol for fluconazole hypersensitivity in a patient with cryptococcal pneumonitis. Annals of Allergy, Asthma &amp; Immunology. 2012 Jun; 108(6): 466.</p>
<p>16. Patel SJ, Sindher S, <strong>Jariwala SP</strong>, Hudes G. Chronic Urticaria with Monoclonal IgG Gammopathy &ndash; a clinical variant of Schnitzler Syndrome? Annals of Allergy, Asthma &amp; Immunology. 2012 Aug; 109(2): 147-8.</p>
<p>17. Sindher S, <strong>Jariwala SP</strong>, Gilbert J, Rosenstreich D. Resolution of chronic urticaria coincident with vitamin D supplementation. Annals of Allergy, Asthma &amp; Immunology. 2012 Nov; 109(5): 359-60.</p>
<p>18. Jerschow E, McGinn A, de Vos G, Vernon N, <strong>Jariwala SP</strong>, Hudes G, Rosenstreich D. Environmental pesticides and allergies: results from the U.S. National Health and Nutrition Examination Survey 2005-2006. Annals of Allergy, Asthma &amp; Immunology. 2012 Dec; 109(6): 420-5.</p>
<p>19. Parikh P, Kooragayalu S, <strong>Jariwala SP</strong>. Mannose-Binding Lectin Deficiency in a Patient with Multiple Opportunistic Infections, Strongyloidiasis, and Spindle Cell Tumor. Annals of Allergy, Asthma &amp; Immunology. 2013 Feb; 110(2): 120-1.</p>
<p>20. <strong>Jariwala SP</strong>, Benson A, Patel P, Friedman A, Broadway K. An unusual association between Sweet&rsquo;s syndrome and metastatic papillary follicular thyroid carcinoma. Annals of Dermatology. 2013 Feb; 25(1): 84-7.</p>
<p>21. Reid N, <strong>Jariwala SP</strong>, Fodeman J, Jerschow E, Hudes G, Rosenstreich D. Worsening of Contact Dermatitis by Oral Hydroxyzine: A Case Report. Dermatology Online Journal. 2013 Feb; 19(2): 4.</p>
<p>22. Rampur L, <strong>Jariwala SP</strong>, Viau R, Patel P, Rosenstreich D. DRESS syndrome with suspected Strongyloides infection in a patient treated for hepatitis C. Annals of Allergy, Asthma &amp; Immunology. 2013 Aug; 111(2): 138-9.</p>
<p>23.&nbsp;<strong>Jariwala SP</strong>, Toh J, Shum M, de Vos G, Zou K, Sindher S, Patel P, Zou K, Geevarghese A, Tavdy A, Rosenstreich D. Association between asthma-related emergency department visits and pollen concentrations in the Bronx, 2001-2008. <em>Journal of Asthma</em>. 2014 Feb; 51(1): 79-83.</p>
<p>24. Jerschow E, Parikh P, McGinn A, de Vos G, <strong>Jariwala S</strong>, Hudes G, Rosenstreich D. Relationship between urine dichlorophenol levels and asthma morbidity. <em>Annals of Allergy, Asthma &amp; Immunology</em>. 2014 Jun; 112(6): 511-518.</p>
<p>25. Ferastraoaru D, Rosenstreich D, <strong>Jariwala S</strong>. Severe Angioedema Associated With Angiotensin-Converting Enzyme Inhibitor Therapy in Two Patients with Pollen-Food Allergy Syndrome. <em>Journal of Clinical Hypertension</em>. 2015 Jun;17(6):493-4.</p>
<p>26. Guha M, <strong>Jariwala S, </strong>Jinjolava N, Mazer N, Revere E, Riska P, Jerschow E. Toxocariasis presenting as eosinophilic ascites in a postpartum female. <em>Journal of Parasitic Diseases</em>. 2015 Jun; 39(2): 284-6.</p>
<p class="DefaultText">27. Lautenbacher L, <strong>Jariwala SP</strong>, Markowitz M, Rastogi D. Vitamin D and pulmonary function in obese asthmatic children. <em>Pediatr Pulmonol</em>. 2016 Dec;51(12):1276-1283.</p>
<p class="DefaultText">28. Arango S, Reddy V, Rosenstreich D, <strong>Jariwala SP</strong>. Poorly Controlled Asthma and Strongyloidiasis in a Non-Endemic Area of the United States. <em>Annals of Allergy, Asthma &amp; Immunology. </em>2016 Aug;117(2):195-6.</p>
<p class="DefaultText">29. <strong>Jariwala SP</strong>, Keskin T, Achar K, Henner J, Talla G, Rosenstreich D, Santana C. Developing and Pilot Testing an Electronic Medical Record (EMR)-based Allergen Immunotherapy Template. <em>Annals of Allergy, Asthma &amp; Immunology</em>. 2016 Aug;117(2):206-8.</p>
<p class="DefaultText">30. Rampur L, <strong>Jariwala SP</strong>, Hudes G, Rosenstreich D, de Vos G. Effect of ivermectin on allergy-type manifestations in occult strongyloidiasis. <em>Annals of Allergy, Asthma &amp; Immunology</em>. 2016 Oct; 117(4): 423-428.</p>
<p class="DefaultText">31. Soffer G, Toh J, Clements S, <strong>Jariwala SP</strong>. A case of chronic contact dermatitis secondary to blue hair dye. <em>Contact Dermatitis</em>. 2016 Oct; 75(4): 258-9.</p>
<p class="DefaultText">32. Aviv R, Toh J, Eisenberg R, Khanna S, <strong>Jariwala SP</strong>. Zinc deficiency presenting as diarrhea and diffuse erythroderma. <em>Annals of Allergy, Asthma &amp; Immunology</em>. 2016 Dec; 117(6): 707-708.</p>
<p class="DefaultText">33. Shah K, Ferastraoaru D, <strong>Jariwala SP</strong>. Eosinophilia associated with <em>Strongyloides</em> infection, severe asthma, and central bronchiectasis. <em>Annals of Allergy, Asthma &amp; Immunology</em>. 2017 Apr; 118(4):510-511.</p>
<p class="DefaultText">34. Iammatteo M, Ayobami A, <strong>Jariwala SP</strong>, Rosenstreich D. Severe contact dermatitis due to ethylenediamine dihydrochloride in nystatin cream. <em>Journal of Allergy and Clinical Immunology: In Practice</em>. 2017 Sep; 5(5):1448-1450.</p>
<p class="DefaultText">35. Soffer G, Cohen B, Toh J, Edelman D, Garg K, <strong>Jariwala SP. </strong>Successful graded dose challenge to iodixanol radiocontrast media in a patient with delayed anaphylaxis to iohexol. <em>Vascular and Endovascular Surgery</em>. 2018 Jan;52(1):59-60.</p>
<p class="DefaultText">36. Witonsky J, Abraham R, Toh J, Desai T, Shum M, Rosenstreich D, <strong>Jariwala SP. </strong>The Association of Environmental, Meteorological, and Pollen Count Variables with Asthma-related Emergency Department Visits and Hospitalizations in the Bronx. <em>Journal of Asthma</em>.&nbsp;2019 Sep;56(9):927-937.&nbsp;</p>
<p class="DefaultText">37. Sharma K, Abraham R, Mowrey W, Toh J, Rosenstreich D, <strong>Jariwala SP</strong>. The association between pollutant levels and asthma-related emergency department visits in the Bronx after the World Trade Center Attacks. <em>Journal of Asthma</em>. 2018 Oct 25:1-7.</p>
<p class="DefaultText">38. Kordit DS, Reznik M, Leu CS, <strong>Jariwala S</strong>. Longitudinal trends in asthma emergency department visits, pollutant and pollen levels, and weather variables in the Bronx from 2001-2008. <em>Journal of Asthma</em>. 2019 Mar 8:1-8.</p>
<p class="DefaultText">39. Eisenman T, <strong>Jariwala S</strong>, Lovasi G. Urban trees and asthma: a call for epidemiological research. <em>Lancet Respiratory Medicine</em>. 2019 Jul; 7(7): e19-e20.</p>
<p class="DefaultText">40. Mowrey W, Keskin T, Hsia B, Wu S, Aita R, Kwak L, Ferastraoaru D, Rosenstreich D, Jariwala SP. Developing and Pilot Testing ASTHMAXcel, a Mobile App for Adults with Asthma. Journal of Asthma. 2020 Feb 12: 1-17. [Epub ahead of print]</p>
<p class="DefaultText">41. Hsia B, Wu S, Mowrey W, Jariwala SP. Evaluating the ASTHMAXcel Mobile Application Regarding Asthma Knowledge and Clinical Outcomes. Respiratory Care (In Press).</p>
<p class="DefaultText">42. Kooragayalu S, El-Zarif S, Jariwala S. Vaping Associated Pulmonary Injury (VAPI) with superimposed Mycoplasma Pneumoniae Infection. Respiratory Medicine Case Reports. 2020 Jan 8; 29: 100997. [Epub ahead of print]</p>
<p class="DefaultText">43. Ramesh S, <strong>Jariwala S</strong>, Hewitt D. <span style="color: #222222; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Environmental Infection Risks for Outdoor Athletes. <em>Journal of Environmental Health</em>. 2020 Oct 1;83(3):22-7.</span></p>
<p class="DefaultText">44. Goodman B, <strong>Jariwala S</strong>. Dupilumab as a novel therapy to treat adrenergic urticaria. <em>Annals of Allergy, Asthma &amp; Immunology</em>. 2020 Jul 1: <span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">S1081-1206(20)30441-5.</span></p>
<p class="DefaultText">45. Hsia B, Singh A, Njeze O, Cosar E, Mowrey W, Feldman J, Reznik M, <strong>Jariwala SP</strong>. Developing and Evaluating ASTHMAXcel Adventures: A Novel Gamified Mobile App for Pediatric Patients with Asthma. <em>Annals of Allergy, Asthma &amp; Immunology</em>. 2020 Nov; 125(5): 581-588. &nbsp;</p>
<p class="DefaultText">46. Beiser M, Lu V, Paul S, Ni J, Nazar N, Epstein E, Mammen A, Short J, Tomer Y, <strong>Jariwala SP. </strong><span style="color: #201f1e; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Electronic Health Record Usage Patterns: Assessing telemedicine&rsquo;s impact on the provider experience during the COVID-19 pandemic. <em>Telemed J E Health</em>. </span><span style="color: #222222; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">2021 Aug 1;27(8):934-8.</span></p>
<p class="DefaultText">47. Ferastraoaru D, Hudes G, Jerschow E, <strong>Jariwala SP</strong>, Karagic M, de Vos G, Rosenstreich D, Ramesh M. Eosinophilia in Asthma Patients is Protective Against Severe COVID-19 Illness. <em>J Allergy Clin Immunol Pract</em><span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">. 2021 Mar; 9(3): 1152-1162.</span></p>
<p class="DefaultText">48. Camacho-Rivera M, Islam J, Vidot D, <strong>Jariwala SP</strong>. Prevalence and risk factors of COVID-19 physical and mental health symptoms among U.S. adults with allergies. <em>International Journal of Environmental Research and Public Health</em>. 2021 Feb 24; 18(5): 2231. &nbsp;</p>
<p class="DefaultText">49. Tomer Y, Gong M, Keller M, Southern W, Kitsis E, Kajita G, Shapiro L, <strong>Jariwala SP</strong>, Epstein E. Teamwork and leadership under fire at the epicenter of the Covid-19 epidemic in the Bronx. <em>Frontiers in Medicine</em>. 2021 Mar 18; 290. &nbsp;</p>
<p class="DefaultText"><span style="color: #1a1a1a;">50. Feldman JM, Becker J, Arora A, DeLeon J, Hernandez TT, Greenfield N., Wiviott A., <strong>Jariwala S</strong>, Shim C, Federman A, Wisnivesky J. Depressive symptoms and over-perception of airflow obstruction in older adults with asthma. <em>Psychosomatic Med</em>. </span><span style="color: #222222; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">2021 Sep 1;83(7):787-94.</span></p>
<p class="DefaultText">51. Arora S, Hemmige V, Mandke C, Chansoria M, Rawat S, Dravid A, Sethi Y, Medikeri G, <strong>Jariwala S</strong>, Puius Y. Preliminary Results from an Online Registry of Coronavirus Disease-Associated Mucormycosis, India. <em>Emerging Infectious Diseases</em>. <span style="color: #222222; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">2021 Nov;27(11):2963.</span></p>
<p class="DefaultText">52. Kaur S, Rosenstreich D, Cleven K, Spivack S, Grizzanti J, Reznik M, <strong>Jariwala SP</strong>. Severe Asthma in an Adult, Inner-city predominantly African-American and Latinx Population: Demographic, Clinical and Phenotypic Characteristics. <em>Journal of Asthma. </em><span style="color: #222222; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">2021 Nov 25:1-1.</span></p>
<p class="DefaultText"><span style="color: #201f1e; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">53. Su Z, He L, <strong>Jariwala SP</strong>, Zheng K, Chen Y. &ldquo;What is your envisioned future?&rdquo;: towards human-AI enrichment in data work of asthma care. Proceedings of the ACM on Human-Computer Interaction, Computer-Supported Cooperative Work 2022 (In Press).</span></p>
<p class="DefaultText"><span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">54. Oh S, Nair S, Casler A, Nguyen D, Forero J, Joco C, Kubert J, Esses D, Adams D,&nbsp;<strong>Jariwala SP</strong>, Leff J. A prospective observational study evaluating the use of remote patient monitoring in ED discharged COVID-19 patients in NYC. <em>American Journal of Emergency Medicine</em>. 2022 May 1; 54: 64-71.&nbsp;</span></p>
<p class="DefaultText"><span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">55.&nbsp;</span>Ruan E, Beiser M, Lu V, Paul S, Ni J, Nazar N, Liu J, Kim M, Epstein E, Keller M, Kitsis E, Tomer Y, <strong>Jariwala SP. </strong>Physician Electronic Health Record Usage as Affected by the COVID-19 Pandemic. <em>Applied Clinical Informatics</em> (In Press).</p>
<p class="DefaultText">56. Mani K, Miller R, Lin J, Shahani J, <strong>Jariwala SP. </strong>Trends in seasonal pollen and asthma-related morbidity among adults and children in urban settings, 2001-2020. <em>Journal of Asthma </em>(In Press).</p>
<p class="DefaultText">57. Silverstein G, Styke S, Kaur S, Singh A, Green S,&nbsp;<strong>Jariwala SP</strong>, Feldman J. The Relationship between Depressive Symptoms, eHealth Literacy, and Asthma Outcomes in the Context of a Mobile Health Intervention.&nbsp;<em>Psychosomatic Medicine</em> (In Press).&nbsp;</p>
<p class="DefaultText">58. Sun Y, <strong>Jariwala SP</strong>, Reznik M. Measurement of adherence to inhaled corticosteroids by self-report and electronic medication monitoring. <em>Journal of Asthma </em>(In Press).</p>
<p class="DefaultText">59. Hantgan S, <strong>Jariwala SP</strong>. User-centered health applications for asthma. <em>Annals of Allergy, Asthma, &amp; Immunology</em> (In Press).</p>
<p class="DefaultText">60. Feldman J, Ankam J, Barry M, Fruchter N, Becker J, <strong>Jariwala SP</strong>, Shim J, Wisnivesky J, Federman A. A pilot RCT of an intervention to improve perception of lung function in older adults with asthma. <em>American Journal of Respiratory and Critical Care Medicine</em><span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> (In Press).</span></p>
<p class="DefaultText">61. Holtzer R, Feldman J, <strong>Jariwala SP</strong>, Izzetoglu M. Asthma History Influences Gait Performance And Associated Prefrontal Cortex Activation Patterns in Older Adults. <em>Aging Clinical and Experimental Research</em> (In Press).</p>
<p class="DefaultText">62. Sehanobish E, Ye K, Imam K, Sariahmed K, Kurian J, Patel J, Belletti D, Chung Y, <strong>Jariwala SP</strong>, White A, Jerschow E. Elaborate prior approval process delays care of moderate-to-severe asthma patients. <em>Journal of Allergy and Clinical Immunology: Global </em>(In Press).</p>
<p><strong>B. <strong>Books, Chapters in Books, and Review Articles</strong>:</strong></p>
<p>1. <strong>Jariwala SP</strong>. The role of dendritic cells in the immunopathogenesis of psoriasis. <em>Arch Dermatol Res</em>. 2007 Oct; 299(8):359-66.</p>
<p>2. <strong>Jariwala S</strong>, Abrams E, Benson A, Fodeman J, Zheng T. The role of thymic stromal lymphopoietin in the immunopathogenesis of atopic dermatitis. <em>Clinical &amp; Experimental Allergy</em>. 2011 Nov; 41(11): 1515-20.</p>
<p>3. Benson AA, Toh J, Vernon N, <strong>Jariwala SP</strong>. The Role of Vitamin D in the Immunopathogenesis of Allergic Skin Diseases. <em>Allergy</em>. 2012 Mar; 67(3): 296-301.</p>
<p>4.&nbsp;<strong>Jariwala SP</strong>, Rastogi D, Sinha S. Asthma, pulmonary diseases and vocal cord dysfunction. In: Rosenstreich DL, de Vos GS, Jackman A, eds. Manual of Allergy and Immunology for Otolaryngologists. San Diego, CA: Plural Publishing, Inc.; 2015.</p>
<p>5.<strong> Jariwala SP</strong>, Desai T, Rosenstreich D. Allergic Rhinitis: Diagnostic and Therapeutic Implications. <em>Respimirror</em>. 2015 July-Aug; 5(3): 1-2.&nbsp;</p>
<p>6.<strong> Jariwala SP</strong>, Desai T. The Association Between Obesity and Asthma in South Asians. <em>Journal of the American Association of Physicians of Indian Origin</em>. 2016 Jan; 30-35. &nbsp;</p>
<p class="DefaultText">7.&nbsp;<strong>Jariwala SP, </strong>Redding L, Hewitt D. The severely under-recognized public health risk of Strongyloidiasis (Helminths) in North American cities &ndash; a One Health approach. <em>Zoonoses and Public Health</em>. 2017; 64(8): 579-88.</p>
<p class="DefaultText">8. Eisenman T, Churkina G, <strong>Jariwala SP</strong>, Lovasi G, Pataki D, Weinberger K, Whitlow T. Urban trees, air quality, and asthma: an interdisciplinary review. <em>Landscape and Urban Planning</em>. 2019; 187: 47-59.&nbsp;&nbsp;</p>
<p class="DefaultText">9. Doshi H, Hsia B, Shahani J, Mowrey W, <strong>Jariwala SP</strong>. Impact of Technology Based Interventions on Patient Reported Outcomes in Asthma: A Systematic Review. <em>J Allergy Clin Immunol Pract</em><span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">. 2021 Jun; 9(6): 2336-2341. </span></p>
<p class="DefaultText">10. Deshpande P, <strong>Jariwala SP</strong>, Martin L, Golestaneh L. <span style="color: #201f1e; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">The Impact of Technology-based Interventions on Linking Potential Kidney Donors and Transplant Candidates: A Scoping Review. <em>Transplant International</em>. </span><span style="color: #222222; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">2021 Dec;34(12):2781-93.</span></p>
<p class="DefaultText"><span style="color: #222222; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">11. Mosnaim GS, Greiwe J, <strong>Jariwala SP</strong>, Pleasants R, Merchant R. Digital Inhalers and Remote Patient Monitoring for Asthma. <em>The Journal of Allergy and Clinical Immunology: In Practice</em>. 2022 Jun 29 (Online ahead of print).</span></p>
<p class="DefaultText">12. Aksan F, Tanriverdi L, Figueredo CJ, Hasham A, <strong>Jariwala SP</strong>. The Impact of Smartphone Applications on Bowel Preparation, Compliance with Appointments, Cost-effectiveness and Patients&rsquo; Quality of Life for the Colonoscopy Process: A Scoping Review. <em>Saudi Journal of Gastroenterology</em> (In Press).</p>
<p class="DefaultText">13.&nbsp;Sariahmed K, Kurian J, Singh AK, Leyton C, Minuti A, Arora S, Jerschow E, <strong>Jariwala SP. </strong>Social, Political, and Economic Determinants of Access to Biologics: A Scoping Review of Structural Determinants in the Clinical Disparities Literature. <em>Research in Social and Administrative Pharmacy </em>(In Press).</p>

EMR ID

4735

Biography

<p>Sunit P. Jariwala, MD, is Medical Director, Digital Transformation; Director, Clinical & Research Innovation; Co-Director, Montefiore Einstein Asthma Center, and Founding Director, Innovation Biodesign Training Program at Montefiore Einstein. He is also Professor, Medicine at our Albert Einstein College of Medicine. His clinical focus is in the diagnosis and treatment of severe asthma in adults and children.</p><p>After earning his Bachelor of Arts in molecular biology and biochemistry at Rutgers University, Dr. Jariwala attended the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, earning his Doctor of Medicine in 2005. He came to Montefiore Einstein for his postgraduate training, completing his internal medicine residency in 2008, and his allergy/immunology fellowship in 2011. He is currently pursuing his Master of Business Administration in Finance at the University of Massachusetts Amherst Isenberg School of Management.</p><p>Dr. Jariwala&rsquo;s research interests focus on chronic conditions and health disparities, including the development and implementation of innovative health technologies such as mobile applications, applying the social needs-based innovation biodesign framework to create novel health technologies, and investigating health disparities surrounding patients' access to biologic medications. He has shared his work through more than 100 publications in peer-reviewed journals, several book chapters, abstracts, and national and regional presentations. He has also served as an ad hoc reviewer for several national and international medical journals.</p><p>Dr. Jariwala is board certified by the American Board of Allergy and Immunology and the American Board of Preventive Medicine (Clinical Informatics). He is a member of the American Academy of Allergy, Asthma and Immunology and the American Medical Association. In 2008, Dr. Jariwala received the Leo M. Davidoff Award for outstanding achievement in the teaching of medical students. He was listed in <em>New York Times Magazine</em>&rsquo;s &ldquo;New York Rising Stars&rdquo; in 2013, 2014 and 2016.</p>

Visit Type ID

2498

Is Open Scheduling

On

Zocdoc Link

Golda Hudes

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/46432ab0-707b-11ef-966c-5129cf50960f.jpg

First Name

Golda

Last Name

Hudes

NPI

1225119647

Faculty ID

1052

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p style="font-variant: normal; letter-spacing: normal; font-style: normal; font-weight: normal; orphans: 2; widows: 2;"><strong> <span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: small;">Dr. Golda Hudes is a Professor of Medicine (Allergy &amp; Immunology) and of Otorhinolaryngology at Einstein. Her research focuses on asthma and chronic rhinosinusitis. She is a Principal Investigator of multiple clinical trials evaluating the efficacy &amp; safety of traditional and experimental drugs in asthma. Dr. Hudes collaborates with Department of Otorhinolaryngology and Mayo Clinic on the research project evaluating biologic treatment in patients with chronic rhinosinusitis with nasal polyposis. Currently she is investigating the relationship between different asthma phenotypes and COVID 19 infection outcomes as well as persistent eosinophilia etiologic factors in inner city population. Her past research focused on immune changes in patients with bronchial asthma during speleotherapy in karst caves. She has published journal articles, abstracts, review articles and book chapters. She mentored numerous fellows, residents and medical students, rotating through the Allergy Division.</span></span></span></strong></p>
<p style="font-variant: normal; letter-spacing: normal; font-style: normal; font-weight: normal; orphans: 2; widows: 2;"><strong> <span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: small;">Dr. Hudes holds MD and PhD degrees from Tbilisi State Medical Institute (Republic of Georgia, USSR). She completed a fellowship in allergy and internal medicine in Georgia; internships and residencies at Metropolitan Hospital Center, Stony Brook University Medical Center, and Jacobi Medical Center; and the Einstein Allergy/Immunology Fellowship Training Program. Prior to her appointment at Einstein she was head of the Department of Allergy at the Research Institute of Rehabilitation in Tbilisi (USSR).</span></span></span></strong></p>
<p style="font-variant: normal; letter-spacing: normal; font-style: normal; font-weight: normal; orphans: 2; widows: 2;"><strong> <span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: small;">Dr. Hudes is board certified in allergy and immunology; Fellow of the American Academy of Allergy, Asthma, and Immunology; Fellow of American College of Allergy, Asthma &amp; Immunology and a member of the executive committee of the New York Allergy and &amp; Asthma Society, where she has served as president, treasurer, and secretary.</span></span></span></strong></p>
<p style="line-height: 100%; margin-bottom: 0in;">&nbsp;</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

4053

Visit Type ID

2498

Is Open Scheduling

On

Michelle Ng Gong

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/328d3b60-bf8b-11ee-b89e-33007638942c.jpg

First Name

Michelle

Last Name

Gong

NPI

1114946233

Faculty ID

11976

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Gong is the Chief of Critical Care Medicine, Chief of Pulmonary Medicine, and Director of Critical Care Research at Montefiore Medical Center and Professor in Medicine and in Epidemiology and Population Health at Albert Einstein College of Medicine. After receiving an engineering degree at the University of Pennsylvania, Dr. Gong went on to earn a medical degree at the Yale University School of Medicine. She then completed her postdoctoral training at the Beth Israel Hospital in medicine and at the Brigham and Women&rsquo;s Hospital in the Harvard Combined Program in Pulmonary and Critical Care Medicine. She also studied at the Harvard School of Public Health, receiving her Master&rsquo;s degree in Clinical Epidemiology. Prior to coming to Albert Einstein College of Medicine and Montefiore Medical Center, she was Assistant Professor of Medicine in the division of Pulmonary, Critical Care and Sleep Medicine at the Mount Sinai School of Medicine.&nbsp; She joined the Einstein/Montefiore faculty in July 2009.</p>
<p>Dr. Gong is recognized nationally and internationally for her expertise in critical care delivery and management of acute respiratory failure and acute respiratory distress syndrome (ARDS).&nbsp; She has spent her career on improving outcomes in patients along the entire continuum of critical illness from its development to its progression and recovery with an overall focus on the prediction and prevention of acute organ failure and their complications.&nbsp; Nationally, she is a well-respected clinical researcher and trialist in acute injury and critical illness.&nbsp; &nbsp;Continuously funded by the NIH for over 20 years for her work, her research ranges from COVID-19 and ARDS to prevention of delirium, treatment of severe influenza, big data and predictive analytics in risk prediction, and effective clinical decision support systems. Her research has been published in the New England Journal of Medicine and JAMA.&nbsp; She has also been funded by the AHRQ on clinical decision making in ARDS&nbsp; and by the NHLBI for the Montefiore-Sinai Clinical Center for the PETAL Clinical Trials Network focused on the prevention and early treatment of ARDS.</p>
<p>A model clinician-researcher, her scientific projects influence her clinical care, and her patients motivates her research. So it is not surprising that some of her proudest achievements have occurred within her clinical work to improve outcomes for patients within Montefiore.&nbsp; This has included process improvement projects such as the implementation of sedation and delirium protocols and early mobilization in the medical intensive care unit that has reduced duration of mechanical ventilation, length of stay, hospital costs and ICU complications.&nbsp; She has also worked on the incorporation of artificial intelligence to help identify patients at increased risk of poor outcomes at Montefiore and evaluation of clinical decision support systems. She has co-authored the Surviving Sepsis Guidelines on management of patients with COVID-19, published in Intensive Care Medicine.&nbsp;</p>
<p>Dr. Gong is a well-regarded leader in the field of pulmonary and critical care medicine.&nbsp; She is a graduate of the prestigious Executive Leadership in Academic Medicine Fellowship and was the former or current chair of the Critical Care Planning Committee and the Critical Care Assembly for the American Thoracic Society. She is also on the Discovery Oversight Committee that helps plan the direction and agenda for the clinical trials initiative of the Society of Critical Care Medicine.&nbsp; Dr. Gong was awarded the Gotham Icon Award for Champions and Change Makers of New York City by the Museum of the City of New York in 2020. Given her expertise, she has been named to multiple panels to develop clinical practice guidelines, including the American College of Chest Physicians and the American Thoracic Society clinical practice guidelines for liberation from mechanical ventilation and the Surviving Sepsis Campaign guidelines for management of severe COVID-19 in 2020.&nbsp; In these leadership positions, she has had the fortune and privilege to mentor residents, fellows and junior investigators both within and beyond Montefiore into productive, academic careers in medicine.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Gong&rsquo;s clinical focus is on critical care delivery, predictive analytics, and process improvements, such as the implementation of sedation and delirium protocols and early mobilization in the medical intensive care unit, which has reduced the duration of mechanical ventilation, length of stay, hospital costs, and ICU complications.

Research Focus

Current research ranges from acute respiratory distress syndrome to prevention of delirium, treatment of severe influenza, big data and predictive analysis in risk prediction, and effective clinical decision support systems.

Elsevier Profile

EMR ID

5230

Biography

<p>Michelle N. Gong, MD, MS, is a Professor of Medicine and Epidemiology and Population Health at Albert Einstein College of Medicine. She is also the Chief of Critical Care Medicine, Associate Chief of Academic Affairs, and Director of Critical Care Research at Montefiore. Dr. Gong&rsquo;s clinical focus is on critical care delivery, predictive analytics, and process improvements, such as the implementation of sedation and delirium protocols and early mobilization in the medical intensive care unit, which has reduced the duration of mechanical ventilation, length of stay, hospital costs, and ICU complications. She joined the Einstein/Montefiore faculty in July 2009.</p> <p>Dr. Gong received an Engineering degree at the University of Pennsylvania. She then went on to earn her Doctor of Medicine at the Yale University School of Medicine. She completed her postdoctoral training at the Beth Israel Hospital in medicine and at the Brigham and Women&rsquo;s Hospital in the Harvard Combined Program in Pulmonary and Critical Care Medicine. Dr. Gong studied at the Harvard School of Public Health, receiving her Master&rsquo;s Degree in Clinical Epidemiology. </p>Dr. Gong has spent her career improving outcomes in patients along the entire continuum of critical illness, from its development to progression and recovery, with an overall focus on the prediction and prevention of acute organ failure and its complications. Her current research ranges from acute respiratory distress syndrome to prevention of delirium, treatment of severe influenza, big data and predictive analysis in risk prediction, and effective clinical decision support systems. Under her leadership, Montefiore/Einstein was selected as a clinical center for the NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network which represents the first representation of a medical center from the New York and the tri-state area. Collaborating with the research informatics and healthcare industries, Dr. Gong has fostered the application of informatic approaches to drive improvement in healthcare delivery and research.</p><p>In 2013, Dr. Gong received the ATS Innovation in Fellowship Education Award. She is board certified by the American Board of Internal Medicine in Internal Medicine, Critical Care Medicine, Palliative Care Medicine, and Pulmonary Medicine. </p>

Is Open Scheduling

Off

Denisa E. Ferastraoaru

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/4f67ca10-b453-11ec-ac66-5b6382c5d80b.jpg

First Name

Denisa

Last Name

Ferastraoaru

NPI

1871866889

Faculty ID

14693

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: black;">Dr. Denisa Ferastraoaru is Associate Professor of Medicine in Allergy and Immunology and attending physician at &nbsp;Einstein/ Montefiore and Jacobi Medical Centers. Dr. Ferastraoaru is board certified in both pediatric and adult Allergy /Immunology and Internal Medicine. She received her medical degree at Carol Davila University of Medicine and Pharmacy in Bucharest, Romania. She completed an Internal Medicine residency at Jacobi Medical Center followed by her Allergy/Immunology fellowship at Montefiore Medical Center. Dr. Ferastraoaru treats both adults and children for a multitude of allergic disorders, including environmental and food allergies, asthma, urticaria, atopic dermatitis, contact dermatitis.&nbsp;</span></p>
<p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><span style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; color: black;">Dr. Ferastraoaru leads the IgE deficiency project where she made important research contributions to the association between absent IgE levels and higher risk of malignancy. In addition, Dr. Ferastraoaru is the Co-Director of the Chronic Sinusitis Clinic at Montefiore where she leads Local Allergic Rhinitis initiative, the only center in the tri-state area for Local Allergic Rhinitis diagnosis and treatment.&nbsp;</span></p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Ferastraoaru sees patients with a variety of allergic conditions: allergic rhinitis, acute and chronic sinusitis, allergic conjunctivitis, itching, skin rashes, urticaria, angioedema, atopic dermatitis, contact dermatitis, I.e. deficiency<quillbot-extension-portal></quillbot-extension-portal><quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

56890

Biography

<p>Denisa Ferastraoaru, MD, is an attending physician and Associate Professor in Allergy-Immunology at Montefiore Einstein. Dr. Ferastraoaru is the Co-Director of the Montefiore Sinus and Allergy Center, where patients are seen by both an Allergist and Otolaryngologist to further diagnose and treat their sinonasal conditions. Dr. Ferastraoaru&rsquo;s clinical focus is on the care of patients with a variety of allergic conditions including allergic rhinitis, acute and chronic sinusitis, allergic conjunctivitis, itching, skin rashes, urticaria, angioedema, atopic dermatitis, contact dermatitis and immunoglobulin E (IgE) deficiency.</p>
<p>Educated in Romania, Dr. Ferastraoaru completed her medical education at University of Medicine and Pharmacy &ldquo;Carol Davila&rdquo; Bucharest. She then completed her Master in Bioengineering and Biotechnology – Medical and Clinical Engineering at Polytechnic University of Bucharest. She began her postgraduate training with a three-year allergy and clinical immunology residency at Nicolae Malaxa Hospital in Bucharest. She then came to the United States for further training at Einstein, completing a three-year residency in internal medicine followed by a two-year allergy-immunology fellowship.</p>
<p>Dr. Ferastraoaru’s research focus is in allergic rhinitis, sinusitis, local allergic rhinitis, skin rashes, and characterizing patients with IgE deficiency and their associated conditions. She is one of the very few providers in the USA who diagnoses and treats patients with local allergic rhinitis. Dr. Ferastraoaru is also among the very few researchers in the world who is studying IgE deficiency, being invited to lecture about this medical condition at several international meetings. She is mentoring students, residents and fellows in the field of Allergy-Immunology and she has shared her work through peer-reviewed journals, book chapters, abstracts and poster presentations. Dr. Ferastraoaru has been featured in different media healthcare platforms, where she provides education materials for patients with allergies.</p>
<p>Dr. Ferastraoaru is board certified in Internal Medicine and Allergy and Immunology. She is a member of the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology and the New York Allergy and Asthma Society. She has been selected among New York Top Doctors & Rising Stars by <em>New York Times Magazine</em> from 2018 through 2022.</p>

Visit Type ID

2498

Is Open Scheduling

On

Zocdoc Link